CRISPR Therapeutics AG - Cash Flow Statement (TTM)

CRISPR Therapeutics AG
CH ˙ BRSE
Cash Flow Statement (TTM)

CRISPR Therapeutics AG Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash From Operating Activities -154 -238 -287 549 544 539 504 -445 -468 -496 -352 -343 -278 -260 -159 -122 -189 -143 -306 -325
Change (%) 55.01 20.34 -291.54 -1.02 -0.89 -6.42 -188.14 5.37 5.83 -29.06 -2.48 -19.06 -6.22 -38.77 -23.62 55.07 -24.38 114.66 5.97
% of Cash Flow -36.21 -100.72 -115.60 77.02 -1,820.79 -219.52 -114.09 38.60 90.42 69.25 102.04 607.34 -948.58 -147.10 -43.94 -309.06 62.44 156.39 64.90 111.66
Cash From Investing Activities -330 -541 -706 -996 -1,231 -1,035 -982 -744 -92 -259 -26 247 281 375 159 -185 -468 -280 -202 -6
Change (%) 64.06 30.47 41.08 23.58 -15.88 -5.16 -24.19 -87.66 181.64 -89.83 -1,037.57 13.74 33.53 -57.56 -216.22 153.10 -40.04 -27.83 -97.26
% of Cash Flow -77.68 -228.67 -284.54 -139.64 4,121.60 421.72 222.14 64.65 17.73 36.13 7.63 -436.81 958.62 211.66 43.83 -469.10 154.68 307.24 42.87 1.91
Cash From Financing Activities 908 1,016 1,241 1,160 657 251 36 38 42 39 33 40 26 63 363 346 354 332 37 39
Change (%) 11.88 22.13 -6.53 -43.34 -61.82 -85.81 5.36 13.06 -9.01 -13.59 19.23 -34.10 139.15 479.59 -4.74 2.34 -6.23 -88.96 7.43
% of Cash Flow 213.89 429.38 500.11 162.61 -2,200.74 -102.21 -8.05 -3.26 -8.19 -5.39 -9.67 -70.40 89.53 35.40 100.10 878.15 -117.08 -363.65 -7.76 -13.53
Cash Flow 425 237 248 713 -30 -246 -442 -1,152 -518 -716 -345 -56 29 177 363 39 -302 -91 -472 -291
Change (%) -44.27 4.86 187.47 -104.19 722.09 80.06 160.50 -55.01 38.18 -51.85 -83.62 -151.83 504.78 104.97 -89.14 -867.58 -69.81 417.29 -38.41
% of Cash Flow 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Other Listings
GB:0VRQ
US:CRSP US$ 54,86
MX:CRSP N
DE:1CG
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista